Report Id: SNS/HC/1849 | June 2022 | Region: Global | 125 Pages
Global Artificial Intelligence in Diagnostics Market is estimated to reach $162.9billion by 2028, growing at a 27.4 percent compound annual growth rate (CAGR). One of the most significant scientific advances in medicine to date is artificial intelligence in healthcare. A crucial aspect contributing to the sector's growth is the involvement of multiple start-ups in the development of AI-driven imaging and diagnostic products.
Image collecting, processing, aided reporting, follow-up, data storage, data mining, and other artificial intelligence applications are all available. The paper strikes a balance between AI's risks and radiologists' prospects in today's medical world. Machine learning blends computational models and algorithms with artificial neural networks to mimic the brain's biological neural network architecture (ANNs). Deep learning has a better success rate than traditional machine learning in terms of output.
The increasing amount of data to be processed has the potential to change how radiologists evaluate images, affecting everything from inference to identification and explanation. When radiologists process too many images in a day, the chances of error increase, and the radiologist's role is limited to that of a pure image analyst. Other physicians or specialists should be entrusted with the clinical interpretation of the data. In other words, if radiologists don't have time for professional judgement, or if there aren't enough radiologists in places like India or Eastern Europe, or if there aren't enough radiologists in Africa, the final evaluation of radiological testing will be left to non-medical imaging experts.
COVID-19 impact on the Artificial Intelligence in Healthcare Market
Due to the increased adoption of AI and ML solutions in the healthcare sector, the AI in healthcare market has historically seen considerable growth. The outbreak of the COVID-19 pandemic provided a chance to demonstrate AI's prowess and sophistication in the healthcare industry. During the pandemic's second wave, hospitals and clinics all over the world used AI-based virtual assistants, inpatient care bots, and AI-assisted surgery robots to deal with the constant influx of patients, which would have otherwise swamped the entire hospital operation cycle.
The market is predicted to flourish over the next 5 to 10 years, with countries such as the United States, Germany, France, China, India, Japan, and South Korea devoting cash to research AI applications in the healthcare sector.
The market is being driven by a growing number of cross-industry partnerships and collaborations, as well as an increasing imbalance between health workforce and patients, which is driving the need for improved healthcare services. The market is also being driven by increasing demand to reduce rising healthcare costs, improving computing power and declining hardware costs, and a growing number of cross-industry partnerships and collaborations.
Improving computing power and declining hardware cost
In recent years, the growing adoption of AI has become a new growth engine for semiconductor chipset manufacturers. Nvidia, AMD, Intel, Qualcomm, Huawei, and Samsung, among others, have made major investments in this field to produce chipsets that are compatible with AI-based technologies and solutions. Application-specific integrated circuits (ASICs) and field-programmable gate arrays (FPGAs) are being developed for AI applications in addition to CPUs and GPUs. Google, for example, has developed a new ASIC called the tensor processing unit (TPU).
One of the important criteria for processing AI algorithms is a compute-intensive chipset; the faster the chipset, the faster it can process the data required to develop an AI system. Currently, AI chipsets are primarily used in data centres and high-end servers because end PCs are unable to handle such large workloads and lack the necessary power and time. Nvidia offers a variety of GPUs with different GPU memory bandwidth options depending on the application. The GeForce GTX Titan X, for example, has a memory bandwidth of 336.5 GB/s and is primarily utilised in desktops, but the Tesla V100 16 GB has a memory bandwidth of 900 GB/s and is primarily used in AI applications.
Nvidia's Tesla V100 (32 GB) is also employed in high-performance computing tasks. It has a two-fold increase in throughput over its predecessor and a throughput of 300 GB/s, allowing it to unleash the greatest application performance feasible on a single server for roughly the same price (USD 8,799).
The cost of a few AI hardware devices has dropped dramatically in the last year, increasing the adoption of AI in new applications and driving the AI chipsets market forward.
Reluctance among medical practitioners to adopt AI-based technologies
With the rapid advancement of digital health and mobile health technology, healthcare providers can now support patients with unique treatment options. Doctors can use AI technologies to help them diagnose and treat patients more effectively. Doctors, on the other hand, have shown a reluctance to adopt new technologies. For example, there is a widespread belief among medical professionals that AI will eventually replace doctors. Doctors and practitioners feel that qualities like empathy and persuasion are human abilities, and that technological advancements cannot totally eliminate the need for a doctor.
Furthermore, there is risk that patients would become overly reliant on these technologies and will forego critical in-person treatments, thus jeopardising long-term doctor-patient relationships. Several healthcare practitioners now have reservations regarding AI technologies' ability to effectively diagnose medical problems. Given this, persuading providers that AI-based solutions are cost-effective, efficient, and safe solutions that provide doctors with convenience as well as better patient care is difficult.
Healthcare providers, on the other hand, are increasingly accepting of the potential benefits of AI-based solutions and the range of applications they can support. As a result, it's possible that doctors will become increasingly interested in AI-based healthcare technology in the coming years.
During the growth of AI technologies, the actual projections intended to make these technologies human-aware, i.e., constructing models with human-like cognitive properties. The inventors of AI machines, on the other hand, face a hurdle in constructing interactive and scalable machines. Furthermore, as human influence with AI approaches has increased, new research challenges have emerged, such as interpretation and presentation issues with automating parts and intelligent control of crowdsourcing parts. The difficulties that AI computers encounter in understanding human input, such as knowledge and particular commands, are referred to as interpretation issues.
Issues with delivering the AI system's output and feedback are among the presentation concerns. Because of the complexity of the output, feedback can be interpreted in a variety of ways. To avoid any ambiguity, the output must be provided exactly as it was intended. This can be difficult if the intended user does not have a strong understanding of the technology. As a result, the development of human-aware AI systems remains the most promising avenue for AI researchers.
In the field of medicine, AI has a number of applications. However, due to data privacy issues, AI use in the sector is limited. In several nations, federal regulations protect patient health data, and any compromise or failure to maintain its integrity can result in legal and financial penalties. Because AI for patient care necessitates access to a variety of health information, AI-based technologies must follow all data security procedures put forth by governments and regulatory agencies. This is a difficult undertaking because most AI platforms are consolidated and require significant computational capacity, necessitating the storage of patient data, or portions of it, in a vendor's data centre.
The vendor data centres are not secure enough to prevent data breaches because the data is available to a wide range of employees, making it difficult to contain breaches. If patient data is accidentally exposed from these data centres, it can result in massive lawsuits and settlement demands from aggrieved parties. This is a significant market challenge.
Many companies are developing software solutions for a variety of healthcare applications, which is a crucial reason in the software segment's growth. Strong demand among software developers (particularly at medical institutions and colleges) and expanding AI applications in the healthcare industry are two major drivers driving the AI platform's rise in the software market. Google AI Platform, TensorFlow, Microsoft Azure, Premonition, Watson Studio, Lumiata, and Infrrd are some of the top AI platforms.
Increasing Adoption of Artificial Intelligence in Healthcare Sector
Growing Investment in Healthcare Sector
Rising Economic Burden on Medical Facilities
Requirement of High Initial Investment
HeartFlow, Inc., Therapixel SA, Nano-X Imaging Ltd., Prognos Health Inc., Butterfly Network, Inc., Aidence B.V., Siemens AG, GE Healthcare, Digital Diagnostics Inc., IBM, and other players.
Natural Language Processing
By Industry Vertical
IT and Telecommunication
Retail and E-commerce
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2021||US$ xx Billion|
|Market Size by 2028||US$ 162.9Billion|
|CAGR||CAGR of 9.8% From 2022 to 2028|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Component (Hardware, Software, Services)
• By Technology (Machine Learning, NLP, Context-Aware Computing, Computer Vision)
• By Diagnosis Type (Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology)
• By Geographic Scope And Forecast 2020-2027
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||HeartFlow, Inc., Therapixel SA, Nano-X Imaging Ltd., Prognos Health Inc., Butterfly Network, Inc., Aidence B.V., Siemens AG, GE Healthcare, Digital Diagnostics Inc., IBM, and other players.|
Frequently Asked Questions (FAQ) :
Ans. Manufacturer and service provider, research institutes, university and private libraries, suppliers and distributers.
Ans. Top-down, bottom-up, Quantitative, Qualitative Research, Descriptive, Analytical, Applied, Fundamental Research.
Ans. Rising Economic Burden on Medical Facilities and Requirement of High Initial Investment these are major challenges faced by them.
Ans. Heart flow, Inc., Thera pixel SA, Nano-X Imaging Ltd., Pro genos Health Inc., and Butterfly Network, Inc. are top key players of this market.
Ans. Market is expected to growing at a 27.4% CAGR over the forecasted period of 2022 to 2028
Table of Content
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4.1 COVID 19 Impact Analysis
4.3 Ukraine Russia Crisis
5.Value Chain Analysis
6.Porter’s 5 forces model
8.The SNS Graph
9.Teleportation Market Segmentation, By Component
10.Teleportation Market Segmentation, By Technology
10.1 Machine Learning
10.2 Natural Language Processing
10.3 Computer Vision
11.Teleportation Market Segmentation, By Industry Vertical
11.1 IT and Telecommunication
11.2 Retail and E-commerce
12.Social Networks Software Market, By Region/ country
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13. Company Profiles
13.1 HFCL Limited
13.3 Products/ Services Offered
13.4 SWOT Analysis
13.5 The SNS view
13.3 Aubot Pty Ltd.
13.4 Tata Communications
13.5 Liquid Intelligent Technologies
13.6 SES S.A.
13.7 Bharti Airtel Limited
13.9 One Web
13.11 Viasat, Inc.
13.12 Eutelsat S.A.
13.13 Theia Holdings
13.15 China Weitong Group Co., Ltd
13.16 China Telecom Corporation
13.17Huaxun Ark Technology Co., Ltd
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share analysis
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.